Related Experiment Video
Updated: Oct 2, 2025

Nasal Brushing Sampling and Processing Using Digital High Speed Ciliary Videomicroscopy – Adaptation for the COVID-19 Pandemic
Published on: November 7, 2020
Coronavirus disease 2019 and pediatric asthma: friend or foe?
1Section of Allergy and Clinical Immunology, Department of Pediatrics, University of Manitoba, Winnipeg, Manitoba, Canada.
Insights
Children with asthma may face a reduced risk of asthma exacerbations during the COVID-19 pandemic. Current asthma medications should be continued, as their impact on coronavirus disease 2019 outcomes remains unclear.
Area of Science:
- Pediatric respiratory health
- Infectious disease epidemiology
Background:
- The relationship between asthma and coronavirus disease 2019 (COVID-19) in pediatric populations requires clarification.
- Understanding this interplay is crucial for managing respiratory conditions during a global pandemic.
Purpose of the Study:
- To review the current evidence on the interplay between childhood asthma and COVID-19.
- To assess the impact of asthma and its treatments on COVID-19 outcomes in children.
Main Methods:
- Systematic review of existing literature.
- Analysis of epidemiological data and clinical observations.
Main Results:
- No evidence suggests asthma increases the risk of severe COVID-19 outcomes in children.
- Some data indicate atopic asthma may reduce asthma exacerbations during the COVID-19 pandemic.
- The effect of asthma therapeutics on COVID-19 is uncertain, but continued use is recommended.
Conclusions:
- Childhood asthma does not appear to be a significant risk factor for severe COVID-19.
- Continued adherence to asthma management plans is advised.
- Social determinants of health warrant increased attention in the context of the pandemic.
Purpose Of Review:
The interplay of asthma and coronavirus disease 2019 (COVID-19) in children is yet unknown. The purpose of this review is to determine the interplay of asthma and asthma therapeutics and COVID-19.
Recent Findings:
There is no evidence to date that asthma is a risk factor for more severe COVID-19 outcomes, especially in children. There is actually some basis to suggest that children with atopic asthma may be at reduced risk of asthma exacerbations during COVID-19. The impact of asthma therapeutics on COVID-19 outcomes is unclear, but guidance is relatively uniform in recommending that those with asthma remain on current asthma medications. A focus on social determinants of health may be increasingly important during the pandemic and beyond.
Summary:
Asthma in children appears to be more friend, than foe, during COVID-19.
Related Concept Videos
Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma-I: Introduction
Asthma-II: Pathophysiology and Classification
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Asthma-III: Symptoms and Complications
Classification of Asthma
Asthma-IV: Nursing Management
First, in...

